Tag: Bill Lobb

A 10-year review (2009-2018) of market access of pharmaceuticals in the EU5 and US.

December 1, 2019
Read More

Market access trends across the EU5 and US: 2009 to 2018 – an update.

June 1, 2019
Read More

EU5 market access for medicines approved under exceptional circumstances.

December 1, 2018
Read More

Market access trends for advanced therapy medicinal products (ATMPs) in Europe.

December 1, 2018
Read More

EU5 market access for medicines with conditional marketing authorisations.

December 1, 2018
Read More

Market access trends across the EU5: 2009 to 2016—an update.

December 1, 2017
Read More

Market access of cellular and gene therapy products in the US and EU5.

June 1, 2017
Read More

Advanced therapy medicinal products (ATMPs) in Europe 8 years on: what is the path to market access so far?

November 1, 2016
Read More

Market access trends across the EU5: 2010 to 2015.

June 1, 2016
Read More
Categories

let's talk!